CTLA4 and cancer: Furthermore, recent studies searching for the effective immunotherapies in cancer and found that ICIs were successful cancer treatments, particularly in metastatic urothelial cancer and melanoma where anti-CTLA-4/PD-1/PD-L1 antibodies have found widespread application (27, 49, 50).